Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annarita Tagliaferri

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Blood Transfusion = Trasfusione Del Sangue|July 14, 2012
The expanding role of prophylaxis with recombinant activated factor VIIAnnarita Tagliaferri, Massimo Franchini
Seminars in Thrombosis and Hemostasis|September 26, 2013
Old and new challenges in hemophilia managementAntonio Coppola, Annarita Tagliaferri, Massimo Franchini
Thrombosis and Haemostasis|April 8, 2009
Prophylaxis in people with haemophiliaAntonio Coppola, Massimo Franchini, Annarita Tagliaferri
Blood Transfusion = Trasfusione Del Sangue|July 23, 2020
Therapeutic choices in persons with haemophilia at the time of COVID-19Antonio Coppola, Federica Riccardi, Annarita Tagliaferri
Seminars in Thrombosis and Hemostasis|July 2, 2016
Controversies in Inherited Bleeding DisordersAntonio Coppola, Annarita Tagliaferri, Massimo Franchini
Seminars in Thrombosis and Hemostasis|April 15, 2010
The management of cardiovascular diseases in patients with hemophiliaAntonio Coppola, Annarita Tagliaferri, Massimo Franchini
Clinical Interventions in Aging|November 30, 2007
The management of hemophilia in elderly patientsMassimo Franchini, Annarita Tagliaferri, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis|September 1, 2018
Alloantibodies and Congenital Bleeding Disorders: New Insights in the Pathogenesis and ManagementAntonio Coppola, Annarita Tagliaferri, Cristina Santoro, et al.
Seminars in Thrombosis and Hemostasis|September 10, 2013
FEIBA versus NovoSeven in hemophilia patients with inhibitorsMassimo Franchini, Antonio Coppola, Annarita Tagliaferri, et al.
Critical Reviews in Oncology/Hematology|February 1, 2011
Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: a critical systematic reviewMassimo Franchini, Annarita Tagliaferri, Carlo Mengoli, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Blood Transfusion = Trasfusione Del Sangue|July 14, 2012
The expanding role of prophylaxis with recombinant activated factor VIIAnnarita Tagliaferri, Massimo Franchini
Seminars in Thrombosis and Hemostasis|September 26, 2013
Old and new challenges in hemophilia managementAntonio Coppola, Annarita Tagliaferri, Massimo Franchini
Thrombosis and Haemostasis|April 8, 2009
Prophylaxis in people with haemophiliaAntonio Coppola, Massimo Franchini, Annarita Tagliaferri
Blood Transfusion = Trasfusione Del Sangue|July 23, 2020
Therapeutic choices in persons with haemophilia at the time of COVID-19Antonio Coppola, Federica Riccardi, Annarita Tagliaferri
Seminars in Thrombosis and Hemostasis|July 2, 2016
Controversies in Inherited Bleeding DisordersAntonio Coppola, Annarita Tagliaferri, Massimo Franchini
Seminars in Thrombosis and Hemostasis|April 15, 2010
The management of cardiovascular diseases in patients with hemophiliaAntonio Coppola, Annarita Tagliaferri, Massimo Franchini
Clinical Interventions in Aging|November 30, 2007
The management of hemophilia in elderly patientsMassimo Franchini, Annarita Tagliaferri, Pier Mannuccio Mannucci
Seminars in Thrombosis and Hemostasis|September 1, 2018
Alloantibodies and Congenital Bleeding Disorders: New Insights in the Pathogenesis and ManagementAntonio Coppola, Annarita Tagliaferri, Cristina Santoro, et al.
Seminars in Thrombosis and Hemostasis|September 10, 2013
FEIBA versus NovoSeven in hemophilia patients with inhibitorsMassimo Franchini, Antonio Coppola, Annarita Tagliaferri, et al.
Critical Reviews in Oncology/Hematology|February 1, 2011
Cumulative inhibitor incidence in previously untreated patients with severe hemophilia A treated with plasma-derived versus recombinant factor VIII concentrates: a critical systematic reviewMassimo Franchini, Annarita Tagliaferri, Carlo Mengoli, et al.
Pageof 8